The reduction of the cerebral glucose metabolism is closely related to the activation of the NOD-like receptor protein 3 (NLRP3) inflammasome in Alzheimer’s disease (AD); however, its underlying mechanism remains unclear. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.